肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2017 梅奥复发性多发性骨髓瘤的治疗指南

2017-03-10 Mayo Clin Proc. 2017 Mar 10.

梅奥复发性多发性骨髓瘤治疗指南

由于各种新药物的出现，多发性骨髓瘤患者的平均寿命正在不断增加。2015年有5种药物被批准用以复发性多发性骨髓瘤。本文主要针对复发性骨髓瘤的诊断评估以及不同阶段疾病复发患者的管理决策提出指导建议。 拓展指南：[[骨髓瘤|5]]

中文标题：

2017 梅奥复发性多发性骨髓瘤的治疗指南

英文标题：

Therapy for Relapsed Multiple Myeloma: Guidelines From the Mayo Stratification for Myeloma and Risk-Adapted Therapy.

发布机构：

发布日期：

2017-03-10

简要介绍：

由于各种新药物的出现，多发性骨髓瘤患者的平均寿命正在不断增加。2015年有5种药物被批准用以复发性多发性骨髓瘤。本文主要针对复发性骨髓瘤的诊断评估以及不同阶段疾病复发患者的管理决策提出指导建议。


拓展指南：与骨髓瘤相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2017 梅奥复发性多发性骨髓瘤的治疗指南)] GetToolGuiderByIdResponse(projectId=1, id=a0d101c00139603a, title=2017 梅奥复发性多发性骨髓瘤的治疗指南, enTitle=Therapy for Relapsed Multiple Myeloma: Guidelines From the Mayo Stratification for Myeloma and Risk-Adapted Therapy., guiderFrom=Mayo Clin Proc. 2017 Mar 10., authorId=null, author=, summary=由于各种新药物的出现，多发性骨髓瘤患者的平均寿命正在不断增加。2015年有5种药物被批准用以复发性多发性骨髓瘤。本文主要针对复发性骨髓瘤的诊断评估以及不同阶段疾病复发患者的管理决策提出指导建议。 拓展指南：[[骨髓瘤|5]], cover=, journalId=null, articlesId=null, associationId=null, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Fri Mar 10 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=由于各种新药物的出现，多发性骨髓瘤患者的平均寿命正在不断增加。2015年有5种药物被批准用以复发性多发性骨髓瘤。本文主要针对复发性骨髓瘤的诊断评估以及不同阶段疾病复发患者的管理决策提出指导建议。 <div><br> </div> 拓展指南：<strong>与<font color=red>骨髓瘤</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=2c4f91c001381e19" title="聚乙二醇化脂质体阿霉素治疗恶性淋巴瘤及多发性骨髓瘤的中国专家共识2016年" target=_blank>聚乙二醇化脂质体阿霉素治疗恶性淋巴瘤及多发性骨髓瘤的中国专家共识2016年</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=bdc0c1c001350aa1" title="2017 BSH指南：骨髓瘤晚期和长期结果的筛查和管理及其治疗" target=_blank>2017 BSH指南：骨髓瘤晚期和长期结果的筛查和管理及其治疗</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=413a21c0013a86cc" title="2017 NCCN临床实践指南：多发性骨髓瘤-证据块（2017.V3）" target=_blank>2017 NCCN临床实践指南：多发性骨髓瘤-证据块（2017.V3）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=965121c001333687" title="2017 NCCN临床实践指南：多发性骨髓瘤-证据块（2017.V2）" target=_blank>2017 NCCN临床实践指南：多发性骨髓瘤-证据块（2017.V2）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=9aea71c001318e3a" title="2016 SIN立场声明：体外轻链去除技术治疗多发性骨髓瘤导致的急性肾损伤" target=_blank>2016 SIN立场声明：体外轻链去除技术治疗多发性骨髓瘤导致的急性肾损伤</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E9%AA%A8%E9%AB%93%E7%98%A4" target=_blank>有关骨髓瘤更多指南</a></ul>, tagList=[TagDto(tagId=9994, tagName=梅奥), TagDto(tagId=22858, tagName=复发性), TagDto(tagId=321, tagName=多发性骨髓瘤), TagDto(tagId=65, tagName=治疗), TagDto(tagId=63, tagName=指南)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4218, appHits=220, showAppHits=0, pcHits=2976, showPcHits=1733, likes=125, shares=5, comments=4, approvalStatus=1, publishedTime=Fri Mar 17 17:16:54 CST 2017, publishedTimeString=2017-03-10, pcVisible=1, appVisible=1, editorId=5295982, editor=yanqin, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=yanqin, createdTime=Fri Mar 17 17:16:54 CST 2017, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 03:13:05 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2017 梅奥复发性多发性骨髓瘤的治疗指南)])
2017 梅奥复发性多发性骨髓瘤的治疗指南
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=186463, encodeId=01b618646341, content=棒棒棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34e51970199, createdName=1e15c325m90(暂无匿称), createdTime=Mon Apr 10 20:14:31 CST 2017, time=2017-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=183768, encodeId=7137183e68bc, content=Mayo！thanks!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc8d2044041, createdName=1771ea4f65m, createdTime=Thu Mar 30 11:18:37 CST 2017, time=2017-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180953, encodeId=d38b18095301, content=签到学习了很多。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Sat Mar 18 19:29:00 CST 2017, time=2017-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180641, encodeId=eca1180641b3, content=指南更新很快, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170207/IMG589913E36908D4741.jpg, createdBy=99331680071, createdName=knowheart, createdTime=Fri Mar 17 18:24:59 CST 2017, time=2017-03-17, status=1, ipAttribution=)]
    2017-04-10 1e15c325m90(暂无匿称)

    棒棒棒

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=186463, encodeId=01b618646341, content=棒棒棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34e51970199, createdName=1e15c325m90(暂无匿称), createdTime=Mon Apr 10 20:14:31 CST 2017, time=2017-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=183768, encodeId=7137183e68bc, content=Mayo！thanks!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc8d2044041, createdName=1771ea4f65m, createdTime=Thu Mar 30 11:18:37 CST 2017, time=2017-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180953, encodeId=d38b18095301, content=签到学习了很多。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Sat Mar 18 19:29:00 CST 2017, time=2017-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180641, encodeId=eca1180641b3, content=指南更新很快, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170207/IMG589913E36908D4741.jpg, createdBy=99331680071, createdName=knowheart, createdTime=Fri Mar 17 18:24:59 CST 2017, time=2017-03-17, status=1, ipAttribution=)]
    2017-03-30 1771ea4f65m

    Mayo！thanks!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=186463, encodeId=01b618646341, content=棒棒棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34e51970199, createdName=1e15c325m90(暂无匿称), createdTime=Mon Apr 10 20:14:31 CST 2017, time=2017-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=183768, encodeId=7137183e68bc, content=Mayo！thanks!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc8d2044041, createdName=1771ea4f65m, createdTime=Thu Mar 30 11:18:37 CST 2017, time=2017-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180953, encodeId=d38b18095301, content=签到学习了很多。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Sat Mar 18 19:29:00 CST 2017, time=2017-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180641, encodeId=eca1180641b3, content=指南更新很快, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170207/IMG589913E36908D4741.jpg, createdBy=99331680071, createdName=knowheart, createdTime=Fri Mar 17 18:24:59 CST 2017, time=2017-03-17, status=1, ipAttribution=)]
    2017-03-18 Chongyang Zhang

    签到学习了很多。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=186463, encodeId=01b618646341, content=棒棒棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34e51970199, createdName=1e15c325m90(暂无匿称), createdTime=Mon Apr 10 20:14:31 CST 2017, time=2017-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=183768, encodeId=7137183e68bc, content=Mayo！thanks!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc8d2044041, createdName=1771ea4f65m, createdTime=Thu Mar 30 11:18:37 CST 2017, time=2017-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180953, encodeId=d38b18095301, content=签到学习了很多。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/A3E53E62691178E2F18D7B999FD22131/100, createdBy=f44d2003846, createdName=Chongyang Zhang, createdTime=Sat Mar 18 19:29:00 CST 2017, time=2017-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=180641, encodeId=eca1180641b3, content=指南更新很快, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170207/IMG589913E36908D4741.jpg, createdBy=99331680071, createdName=knowheart, createdTime=Fri Mar 17 18:24:59 CST 2017, time=2017-03-17, status=1, ipAttribution=)]
    2017-03-17 knowheart

    指南更新很快

    0